首页> 外文OA文献 >Multidrug resistance-associated protein 1 (MRP1/ABCC1) polymorphism: from discovery to clinical application
【2h】

Multidrug resistance-associated protein 1 (MRP1/ABCC1) polymorphism: from discovery to clinical application

机译:多药耐药相关蛋白1(MRP1 / ABCC1)多态性:从发现到临床应用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Multidrug resistance-associated protein 1 (MRP1/ABCC1) is the first identified member of ABCC subfamily which belongs to ATP-binding cassette (ABC) transporter superfamily. It is ubiquitously expressed in almost all human tissues and transports a wide spectrum of substrates including drugs, heavy metal anions, toxicants, and conjugates of glutathione, glucuronide and sulfate. With the advance of sequence technology, many MRP1/ABCC1 polymorphisms have been identified. Accumulating evidences show that some polymorphisms are significantly associated with drug resistance and disease susceptibility. In vitro reconstitution studies have also unveiled the mechanism for some polymorphisms. In this review, we present recent advances in understanding the role and mechanism of MRP1/ABCC1 polymorphisms in drug resistance, toxicity, disease susceptibility and severity, prognosis prediction, and methods to select and predict functional polymorphisms.
机译:多药耐药相关蛋白1(MRP1 / ABCC1)是ABCC亚家族的第一个被鉴定成员,属于ATP结合盒(ABC)转运蛋白超家族。它在几乎所有人体组织中普遍表达,并能运输各种底物,包括药物,重金属阴离子,有毒物质以及谷胱甘肽,葡糖醛酸和硫酸盐的结合物。随着序列技术的发展,已经确定了许多MRP1 / ABCC1多态性。越来越多的证据表明,某些多态性与耐药性和疾病易感性显着相关。体外重建研究还揭示了某些多态性的机制。在这篇综述中,我们目前在了解MRP1 / ABCC1多态性在耐药性,毒性,疾病易感性和严重性,预后预测以及选择和预测功能性多态性的方法中的作用和机理方面取得了最新进展。

著录项

  • 作者

    Yin Jiye; Zhang Jianting;

  • 作者单位
  • 年度 2011
  • 总页数
  • 原文格式 PDF
  • 正文语种 en_US
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号